Final Cma Data

  • Upload
    gauseh

  • View
    235

  • Download
    0

Embed Size (px)

Citation preview

  • 8/10/2019 Final Cma Data

    1/25

    Kaveri Tissues Pvt Ltd 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19

    CMA-Form-II audited audited estimated projected p rojected projected projected projected projected

    1 Gross Sales (net of returns):(i). Domestic Sales 5,824.32 8,613.00 12,154.00 12,889.00 13,287.00 13,175.00 13,018.00 13,018.00(ii). Export Sales 960.88 2,610.00 2,916.00 3,278.00 3,574.00 3,740.00 3,897.00 3 ,897.00(ii). Duty Drawback

    Total: 0.00 6,785.20 11,223.00 15,070.00 16,167.00 16,861.00 16,915.00 16,915.00 16,915.002 Less: Excise Duty 531.68 879.00 1,181.50 1,267.50 1,323.00 1,327.00 1,327.00 1,327.00

    Less: Other Items [If any]

    3 Net Sales ( item 1 minus 2 ) 0.00 6,253.52 10,344.00 13,888.50 14,899.50 15,538.00 15,588.00 15,588.00 15,588.004 %age rise/fall in Net Sales as compared to

    previous years #DIV/0! 65.41% 34.27% 7.28% 4.29% 0.32% 0.00% 0.00% Add other revenue incomeTotal Sales including Rev. Income 0.00 6,253.52 10,344.00 13,888.50 14,899.50 15,538.00 15,588.00 15,588.00 15,588.00

    5 Cost of Salesi Raw Materials(incl. stores and other itemsused in the process of mfg ) 3,792.53 5,084.69 6,773.75 7,290.36 7,692.26 7,692.26 7,692.26 7,692.26a. Imported

    b. Indigenous 3,792.53 5,084.69 6,773.75 7,290.36 7,692.26 7,692.26 7,692.26 7,692.26ii Other Spares 1,647.22 2,073.79 2,235.59 2,384.23 2,384.23 2,384.23 2,384.23

    a. Imported

    b. Indigenous 1,647.22 2,073.79 2,235.59 2,384.23 2,384.23 2,384.23 2,384.23iiiPower & Fuel 130.00 1,305.92 1,691.73 1,811.26 1,894.48 1,894.48 1,894.48 1,894.48iv Factory wages&salary 262.44 335.00 351.75 369.34 387.80 407.19 427.55 448.93v Other manufacturing expenses 1,116.91 490.88 617.76 661.44 686.40 686.40 686.40 686.40vi Depreciation 229.35 598.96 556.55 502.54 453.99 410.34 371.09 335.79viiSub-total (items i to vi) 0.00 5,531.23 9,462.67 12,065.33 12,870.53 13,499.16 13,474.90 13,456.01 13,442.09viii Add : Opening Stocks in Process 4.63 17.98 475.57 491.18 528.26 549.08 549.08 549.08

    Sub-total 0.00 5 ,535.86 9,480.65 12,540.90 13,361.71 14,027.42 14,023.98 14,005.09 13,991.17ix Deduct : Closing Stocks in Process 4.63 17.98 475.57 491.18 528.26 549.08 549.08 549.08 549.08x Cost of Production -4.63 5,517.88 9,005.08 12,049.72 12,833.45 13,478.34 13,474.90 13,456.01 13,442.09xi Add : Opening Stocks of Finished Goods 26.97 198.95 526.26 543.75 584.86 608.18 608.18 608.18

    Sub-total -4.63 5,544.85 9,204.03 12,575.98 13,377.20 14,063.20 14,083.08 14,064.19 14,050.27xiiDeduct : Closing Stocks of Finished Goods 26.97 198.95 526.26 543.75 584.86 608.18 608.18 608.18 608.18xiiiSub-total: (Total Cost of Sales) -31.60 5,345.90 8,677.77 12,032.23 12,792.34 13,455.02 13,474.90 13,456.01 13,442.09

    6 Selling General & Administrative Expenses335.54 477.65 484.91 489.76 495.85 508.72 508.72 508.72

    7 Sub-total : ( 5+6 ) -31.60 5,681.44 9,155.42 12,517.14 13,282.10 13,950.87 13,983.62 13,964.73 13,950.81

  • 8/10/2019 Final Cma Data

    2/25

    Kaveri Tissues Pvt Ltd 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19

    CMA-Form-II audited audited estimated projected p rojected projected projected projected projected8 Operating Profit before interest (3-7)

    Including Depreciation 31.60 572.08 1,188.58 1,371.36 1,617.40 1,587.13 1,604.38 1,623.27 1,637.19

    Operating Profit before interest (3-7) -Cont. from Page 1 31.6 572.08 1188.58 1371.36 1617.4 1587.13 1604.38 1,623.27 1637.19Interest - Bank - Cash Credit 130.00 398.43 495.78 522.34 554.42 565.29 522.40 515.58

    Interest - Bank Term Loan 294.23 459.94 445.14 345.81 228.69 128.02 73.55 20.079 Net Interest 424.23 858.37 940.92 868.15 783.11 693.31 595.95 535.65

    10 Operating Profit after intrest (8-9) 31.6 147.85 330.21 430.44 749.25 804.02 911.07 1027.32 1101.5411 (i). Add other non-operating income

    a. INTEREST (From Bank) 2.39b. RENTAL INCOME

    c. DUTY DRAWBACK

    d. Others (From IT refund) 0.05 55.49Sub-total (income) 2.44 55.49 0 0 0 0 0 0

    11

    (ii). Deduct other non-operating expenses

    a. Exchange loss

    b. Salary Paid - Partnersc. Interest Paid - Others

    d. Previous year's deferred tax/Others 0.37Sub-total (expenses) 0.37 0 0 0 0 0 0 0

    11

    (iii). Net of other non-operatingincome/expenses 2.07 55.49 0 0 0 0 0 0

    12 Profit before tax / Loss [10+11(iii)] 33.67 203.34 330.21 430.44 749.25 804.02 911.07 1027.32 1101.5413 Provision for Taxes 3.1 0.00 37.38 48.72 82.54 91.02 103.13 128.59 157.2814 Net Profit /Loss (item 12 - 13) 30.57 203.34 292.83 381.72 666.71 713 807.94 898.73 944.26

    a. Equity Dividend paid amount (Already paid+ B.S. Provisions)- Drawings 0b. Dividend payable 0c. Transferred to General Reserve 0

    15 Retained Profit 016 Retained Profit / Net Profit (%age) 0

  • 8/10/2019 Final Cma Data

    3/25

    Kaveri Tissues Pvt Ltd 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18CMA-Form-III audited audited estimated projected projected projected projected projectedLIABILITIESCurrent Liabilitiesfrom Applicant Banks 0.00 0.00 1262.52 1555.94 1773.23 1876.46 1866.23 1928.76From Other Banks 792.38 1115.53 1175.00 1175.00 1175.00 1175.00 1175.00 1175.00Subtotal-STBB 792.38 1115.53 2437.52 2730.94 2948.23 3051.46 3041.23 3103.76Sundry creditors Trade 699.7 172.44 204.68 270.53 291.02 302.3 302.3 302.3Sundry creditors expensesAdvance from customers 105.64 105.64 105.64 105.64 105.64 105.64 105.64Provision for taxation 9.62 37.38 48.72 82.54 91.02 103.13 128.59Dividend payableOther SL payable in 1 year Term Loan Inst 1 year Other Cur liabilites & Prov 192.98 168.04 156.70 122.88 114.40 102.29 76.83

    OCL 709.32 471.06 515.74 581.59 602.08 613.36 613.36 613.36

    Total CL (OCL + BB) 1501.7 1586.59 2953.26 3312.53 3550.31 3664.82 3654.59 3717.12

    Term LiabilitiesTerm Loan from our Bank 2006.00 1872.00 1605.00 1204.00 803.00 401.00TL from Allahabad Bank 2729.06 2414.46 1854.46 1294.46 734.46 174.46 0 0Other Term Loans ICICI 16.61 6.82 0.00 0.00 0.00 0 0 0WBIDC 25.15 25.15 25.15 25.15 25.15 25.15 25.15Unsecured Loan Quasi 1230.25 3123.5 3291.50 3291.50 3291.50 3291.50 3291.50 3291.50Total Term Loans 3975.92 5569.93 7177.11 6483.11 5656.11 4695.11 4119.65 3717.65

    Total Out Side Liabilities 5477.62 7156.52 10130.37 9795.64 9206.42 8359.93 7774.24 7434.77

    Net Worth

  • 8/10/2019 Final Cma Data

    4/25

    Kaveri Tissues Pvt Ltd 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18CMA-Form-III audited audited estimated projected projected projected projected projectedAuthorised Capital 300 400 400 400 400 400 400 400Paid Up Capital 234.47 304.97 345.8 345.8 345.8 345.8 345.8 345.8General Reserve 7.04 210.38 503.21 884.93 1531.54 2244.54 3052.48 3951.21Revaluation ReserveShare Appln Money 22.50Profit & Loss AccountSecurity Premium 465.94 606.94Share premium 688.61 688.61 688.61 688.61 688.61 688.61Total Net Worth 707.45 1144.79 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62

    Total Liabilities 6185.07 8301.31 11667.99 11714.98 11772.37 11638.88 11861.13 12420.39

    Current AssetsCash & Bank Balance 12.9 459.90 938.22 324.46 320.91 399.01 1011.26 1916.61Fixed Deposits with Banks 75.19 95.97Sundry Debtors 284.92 1422.69 1724 2314.75 2483.25 2589.65 2598 2598InventoryRaw Materials 531.3 895.41 966.87 1279.49 1377.56 1455.72 1455.72 1455.72Indigenious 531.3 895.41 966.87 1279.49 1377.56 1455.72 1455.72 1455.72ImportedStock In Process 4.63 17.98 475.57 491.18 528.26 549.08 549.08 549.08Finished Goods 26.97 198.95 526.26 543.75 584.86 608.18 608.18 608.18Other Spares 24.44 53.10 66.83 71.55 74.25 74.25 74.25Advance to Suppliers 352.91Advance Payment of tax 8.72 80.00 91.00 103.00 128.00Other Current Assets 404.74 112.73 112.73 112.73 112.73 112.73 112.73Interest receivable on FD 1.85

    Total Current Assets 1728.57 3090.90 4796.75 5133.19 5559.12 5879.62 6512.22 7442.57

    Fixed Assets

  • 8/10/2019 Final Cma Data

    5/25

    Kaveri Tissues Pvt Ltd 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18CMA-Form-III audited audited estimated projected projected projected projected projectedGross Block 3899.46 5437.03 7637.00 7637.00 7637.00 7637.00 7637.00 7637.00Depreciation 229.35 828.31 1384.86 1887.4 2341.39 2751.74 3122.83Net Block 3899.46 5207.68 6808.69 6252.14 5749.60 5295.61 4885.26 4514.17

    Non Current AssetsPre-operative Expenses 552.76Security Deposit 1.55Adv for Capital GoodsOther Advances 62.55 329.65 463.65 463.65 463.65 463.65Loan to a Director Total Non Current Assets 554.31 0.00 62.55 329.65 463.65 463.65 463.65 463.65

    Intangible AssetsPreliminary Expenses 2.73 2.73OthersTotal Intangible Assets 2.73 2.73 0.00 0.00 0.00 0.00 0.00 0.00

    Total Assets 6185.07 8301.31 11667.99 11714.98 11772.37 11638.88 11861.13 12420.39Total Liabilities 6185.07 8301.31 11667.99 11714.98 11772.37 11638.88 11861.13 12420.39

    Check Diffierence 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

    Tangible Net Worth 704.72 1142.06 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62

    Net Working Capital 226.87 1504.31 1843.49 1820.66 2008.81 2214.80 2857.63 3725.45

    Current Ratio 1.15 1.95 1.62 1.55 1.57 1.60 1.78 2.00

    TOL/TNW 7.77 6.27 6.59 5.10 3.59 2.55 1.90 1.49

    TOL/TNW - Revaluation 7.77 6.27 6.59 5.10 3.59 2.55 1.90 1.49

  • 8/10/2019 Final Cma Data

    6/25

    Kaveri Tissues Pvt Ltd 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18CMA-Form-III audited audited estimated projected projected projected projected projected

    TOL/TNW+QUASI 7.77 6.11 6.47 5.02 3.54 2.52 1.88 1.48

    TOL/TNW adj 36.05 6.27 6.59 5.10 3.59 2.55 1.90 1.49

    Term Debt Equity Ratio 5.64 4.88 4.67 3.38 2.20 1.43 1.01 0.75

  • 8/10/2019 Final Cma Data

    7/25

    31.03.19projected

    1870.621175.003045.62302.3

    105.64157.28

    48.14

    613.36

    3658.98

    0.000025.152691.502716.65

    6375.63

  • 8/10/2019 Final Cma Data

    8/25

    31.03.19projected400345.84895.83

    688.615930.24

    12305.87

    2108.88

    2598

    1455.721455.72

    549.08608.1874.25

    157.00112.73

    7663.84

  • 8/10/2019 Final Cma Data

    9/25

    31.03.19projected7637.003458.624178.38

    463.65

    463.65

    0.00

    12305.8712305.87

    0.00

    5930.24

    4004.86

    2.09

    1.08

    1.08

  • 8/10/2019 Final Cma Data

    10/25

    31.03.19projected

    1.07

    1.08

    0.46

  • 8/10/2019 Final Cma Data

    11/25

    Salient Financial Indicators

    Salient Financial Indicators 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 3Krishna Tissues Pvt Ltd audited audited estimated projected projected projected projected projected projectedAuthorised Capital 300.00 400.00 400.00 400.00 400.00 400.00 400.00 400.00 Paid Up Capital 234.47 304.97 345.80 345.80 345.80 345.80 345.80 345.80 Net Worth 704.72 1142.06 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62 TNW excl Revaluation Reser 704.72 1142.06 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62 TNW less Investments

    in subsidiaries

    TNW treating Unsecured

    Loan as quasi Equity

    Long Term Secured Loans 2745.67 2421.28 3860.46 3166.46 2339.46 1378.46 803.00 401.00 Long Term Un Sec Loans 0.00 25.15 25.15 25.15 25.15 25.15 25.15 25.15 Of which from Promoters 0.00 25.15 25.15 25.15 25.15 25.15 25.15 25.15 Net Fixed Assets 3899.46 5207.68 6808.69 6252.14 5749.60 5295.61 4885.26 4514.17 Capital Work In Progress

    Non current Assets 554.31 0.00 62.55 329.65 463.65 463.65 463.65 463.65 Inventories 587.34 1112.34 2021.80 2381.25 2562.23 2687.23 2687.23 2612.98

    Receivables 284.92 1422.69 1724.00 2314.75 2483.25 2589.65 2598.00 2598.00 Other Current Assets 854.46 555.87 1050.95 437.19 513.64 602.74 1226.99 314.98 Other Current Liabilities

    excluding BB including TL

    Bank Borrowings 792.38 1115.53 2437.52 2730.94 2948.23 3051.46 3041.23 3103.76 Total Current Liabilities 1501.70 1586.59 2953.26 3312.53 3550.31 3664.82 3654.59 3717.12 Net Working Capital 226.87 1504.31 1843.49 1820.66 2008.81 2214.80 2857.63 3725.45 Current Ratio 1.15 1.95 1.62 1.55 1.57 1.60 1.78 2.00 TL Inst due with in 1 year 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Ratio without TL 1.15 1.95 1.62 1.55 1.57 1.60 1.78 2.00 Debt Equity Ratio

    Considering all Out side

    liabilities TOL/TNWTOL/Adj TNW 36.05 6.27 6.59 5.10 3.59 2.55 1.90 1.49 TOL/TNW + Quasi Equity 7.77 6.11 6.47 5.02 3.54 2.52 1.88 1.48 Net Sales 0.00 6253.52 10344.00 13888.50 14899.50 15538.00 15588.00 15588.00 1Operating Profit 31.60 147.85 330.21 430.44 749.25 804.02 911.07 1027.32 Other Income 2.07 55.49 0.00 0.00 0.00 0.00 0.00 0.00 Profit before Depreciation

    Interest & Tax

    Depreciation 0.00 229.35 598.96 556.55 502.54 453.99 410.34 371.09

    4112.04

    613.36

    4086.89

    1994.36

    613.36

    1.49

    4985.62

    5010.77

    7.77 6.27 6.59

    709.32 471.06 515.74

    1.90

    1944.49704.72 1167.21 1562.77

    1919.34

    33.67 856.92 1787.54

    581.59

    5.10

    2591.10 3304.10

    3.59 2.55

    602.08

    151.96 1142.06 1537.62 2565.95 3278.95

    2014.72

    613.36

    1927.91 2119.94 2041.12

  • 8/10/2019 Final Cma Data

    12/25

    Salient Financial Indicators 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31Krishna Tissues Pvt Ltd audited audited estimated projected projected projected projected projected projectedInterest 0.00 424.23 858.37 940.92 868.15 783.11 693.31 595.95 Tax 3.10 0.00 37.38 48.72 82.54 91.02 103.13 128.59 Profit after Tax (PAT) 30.57 203.34 292.83 381.72 666.71 713.00 807.94 898.73 Cash Accruals 30.57 432.69 891.79 938.27 1169.25 1166.99 1218.28 1269.82 % increase in Net sales 0.00 #DIV/0! 65.41 34.27 7.28 4.29 0.32 0.00 % Op Profit/Net Sales #DIV/0! 2.36 3.19 3.10 5.03 5.17 5.84 6.59 % PBDIT/Net Sales #DIV/0! 13.70 17.28 13.88 14.23 13.14 12.92 12.79 % PAT /Net Sales #DIV/0! 3.25 2.83 2.75 4.47 4.59 5.18 5.77 % Interest /Net Sales #DIV/0! 6.78 8.30 6.77 5.83 5.04 4.45 3.82 Return on Capital Employed 0.01 0.13 0.15 0.17 0.19 0.19 0.19 0.18 Interest cover Times

  • 8/10/2019 Final Cma Data

    13/25

    Salient Financial Indicators 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31Krishna Tissues Pvt Ltd audited audited estimated projected projected projected projected projected projected

  • 8/10/2019 Final Cma Data

    14/25

    Particulars 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03audited audited estimated projected projected projected projected projected projected

    Cash & Bank Balance 12.9 459.9 938.22 324.46 320.91 399.01 1011.26 1916.61 21Fixed Deposits with Banks 75.19 95.97 0 0 0 0 0 0 Sundry Debtors 284.92 1422.69 1724 2314.75 2483.25 2589.65 2598 2598 Raw Materials 531.3 895.41 966.87 1279.49 1377.56 1455.72 1455.72 1455.72 14Stock In Process 4.63 17.98 475.57 491.18 528.26 549.08 549.08 549.08 5Finished Goods 26.97 198.95 526.26 543.75 584.86 608.18 608.18 608.18 6Other Spares 24.44 0 53.1 66.83 71.55 74.25 74.25 74.25 Advance Payment of tax 8.72 0 0 0 80 91 103 128 Other Current Assets 404.74 0 112.73 112.73 112.73 112.73 112.73 112.73 Advance to Suppliers 352.91 0 0 0 0 0 0 0 Interest receivable on FD 1.85 0 0 0 0 0 0 0 Total 1728.57 3090.9 4796.75 5133.19 5559.12 5879.62 6512.22 7442.57 7663

    Particulars 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03audited audited estimated projected projected projected projected projected projected

    CC from Applicant Banks 0.00 0.00 1262.52 1555.94 1773.23 1876.46 1866.23 1928.76 18CC From Other Banks 792.38 1115.53 1175.00 1175.00 1175.00 1175.00 1175.00 1175.00 117Sundry creditors Trade 699.70 172.44 204.68 270.53 291.02 302.30 302.30 302.30 3Advance from customers 0.00 105.64 105.64 105.64 105.64 105.64 105.64 105.64 1Provision for taxation 9.62 0.00 37.38 48.72 82.54 91.02 103.13 128.59 Other Cur liabilites & Prov 0.00 192.98 168.04 156.70 122.88 114.40 102.29 76.83 Total 1501.70 1586.59 2953.26 3312.53 3550.31 3664.82 3654.59 3717.12 365

    Break up of Current Assets

    Break up of Current Liabilities

  • 8/10/2019 Final Cma Data

    15/25

  • 8/10/2019 Final Cma Data

    16/25

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18audited audited estimated projected projected projected projected projected

    NWC To TCA 13.12% 48.67% 38.43% 35.47% 36.14% 37.67% 43.88% 50.0BB to TCA 45.84% 36.09% 50.82% 53.20% 53.03% 51.90% 46.70% 41.7

    Sundry Creditors to TCA 40.48% 5.58% 4.27% 5.27% 5.24% 5.14% 4.64% 4.0OCL to TCA 0.56% 9.66% 6.48% 6.06% 5.60% 5.29% 4.78% 4.1Total 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18audited audited estimated projected projected projected projected projected

    Long Term Source 4680.64 6711.99 8714.73 8402.45 8222.06 7974.06 8206.54 8703.27Long Term Application 4453.77 5207.68 6871.24 6581.79 6213.25 5759.26 5348.91 4977.82Long Term Surplus/Deficit 226.87 1504.31 1843.49 1820.66 2008.81 2214.80 2857.63 3725.45Short Term Source 1501.7 1586.59 2953.26 3312.53 3550.31 3664.82 3654.59 3717.12Short Term Application 1728.57 3090.9 4796.75 5133.19 5559.12 5879.62 6512.22 7442.57

    Short Term Surplus/Deficit -226.87 -1504.31 -1843.49 -1820.66 -2008.81 -2214.8 -2857.63 -3725.45

    Funding Pattern of Current Assets

    Source & Application of Funds

  • 8/10/2019 Final Cma Data

    17/25

    31.03.19projected

    52.26%39.74%3.94%4.06%

    100.00%

    31.03.19projected

    8646.894642.034004.863658.987663.84

    -4004.86

  • 8/10/2019 Final Cma Data

    18/25

    Financial Parameters 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Current Ratio 1.15 1.95 1.62 1.55 1.57 1.60 1.78 2.00 TNW ( Rs. in lacs) 704.72 1142.06 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62 5930.2Debt Equity Ratio 7.77 6.27 6.59 5.10 3.59 2.55 1.90 1.49 OpProfit/Sales% #DIV/0! 236.43% 319.23% 309.93% 502.87% 517.45% 584.47% 659.05% 706.6Net Working Capital(Rs) 226.87 1504.31 1843.49 1820.66 2008.81 2214.8 2857.63 3725.45 4004.8

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Assumptions

    Sales Gross 0 6785.2 11223 15070 16167 16861 16915 16915 169Sales Net 0.00 6253.52 10344.00 13888.50 14899.50 15538.00 15588.00 15588.00 15588.0Cost of Production -4.63 5517.88 9005.08 12049.72 12833.45 13478.34 13474.9 13456.01 13442.0Cost of Sales -31.6 5345.9 8677.77 12032.23 12792.34 13455.02 13474.9 13456.01 13442.0Raw Material con 0 3792.53 5084.69 6773.75 7290.36 7692.26 7692.26 7692.26 7692.% COP/Sales #DIV/0! 88.24% 87.06% 86.76% 86.13% 86.74% 86.44% 86.32% 86.%COS/Sales #DIV/0! 85.49% 83.89% 86.63% 85.86% 86.59% 86.44% 86.32% 86.% RM/COP 0.00% 68.73% 56.46% 56.21% 56.81% 57.07% 57.09% 57.17% 57.

    Level of Holdings 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Raw Material

    0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/

    531.3 895.41 966.87 1279.49 1377.56 1455.72 1455.72 1455.72 1455.7

    #DIV/0! 86 69 69 69 69 69 69 24.44 0 53.1 66.83 71.55 74.25 74.25 74.25 7

    4.63 17.98 475.57 491.18 528.26 549.08 549.08 549.08 549-365 1 19 15 15 15 15 15 26.97 198.95 526.26 543.75 584.86 608.18 608.18 608.18 608.-312 14 22 16 17 16 16 16

    284.92 1422.69 1724 2314.75 2483.25 2589.65 2598 2598 259#DIV/0! 77 56 56 56 56 56 56

    Receivables

    Imported

    Work in Progress

    Indegenious

    Conusmable spares

    Finished Goods

  • 8/10/2019 Final Cma Data

    19/25

    779.27 459.9 1050.95 437.19 513.64 602.74 1226.99 2157.34 237845.08% 14.88% 21.91% 8.52% 9.24% 10.25% 18.84% 28.99% 3699.7 172.44 204.68 270.53 291.02 302.3 302.3 302.3 30

    #DIV/0! 17 15 15 15 14 14 14 Other Current Liabilites 9.62 298.62 311.06 311.06 311.06 311.06 311.06 311.06 311

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Raw Materials 531.30 895.41 966.87 1279.49 1377.56 1455.72 1455.72 1455.72 1455Working Progress 4.63 17.98 475.57 491.18 528.26 549.08 549.08 549.08 549Finished Goods 26.97 198.95 526.26 543.75 584.86 608.18 608.18 608.18 608Consumable Spares 24.44 0 53.1 66.83 71.55 74.25 74.25 74.25 Receivables 284.92 1422.69 1724 2314.75 2483.25 2589.65 2598 2598 25Advance to Suppliers 352.91 0 0 0 0 0 0 0 Cash & Bank Balance 12.9 459.9 938.22 324.46 320.91 399.01 1011.26 1916.61 2108Other current assets -191.29 -1355.31 -1905.09 -1603.95 -1698.47 -1854.73 -2466.98 -3372.33 -3564Total Current Assets 1046.78 1639.62 2778.93 3416.51 3667.92 3821.16 3829.51 3829.51 3829.5

    Sundry Creditors 699.7 172.44 204.68 270.53 291.02 302.3 302.3 302.3 30Other Current Liabilities 9.62 298.62 311.06 311.06 311.06 311.06 311.06 311.06 311Working Capital Gap 337.46 1168.56 2263.19 2834.92 3065.84 3207.8 3216.15 3216.15 3216.1

    Computation of Permissible Bank Finance

    2nd Method of lending 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    1. Working Capital Gap 337.46 1168.56 2263.19 2834.92 3065.84 3207.8 3216.15 3216.15 3216.2. Minimum stipulated 261.70 409.91 694.73 854.13 916.98 955.29 957.38 957.38 957 NWC(25% of CA)

    3. Actual/Projected NWC 226.87 1504.31 1843.49 1820.66 2008.81 2214.8 2857.63 3725.45 4004.4. Item (1) - Item (2) 75.77 758.66 1568.46 1980.79 2148.86 2252.51 2258.77 2258.77 2258

    5. Item (1) - Item (3) 110.59 -335.75 419.70 1014.26 1057.03 993.00 358.52 -509.30 -7886. Permissible Bank Finance 75.77 -335.75 419.7 1014.26 1057.03 993 358.52 -5029.3 -788

    Turnover Method 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19

    Sundry Creditors

    Other Current Assets

  • 8/10/2019 Final Cma Data

    20/25

    audited audited estimated projected projected projected projected projected projectedI) 25% of the Sales accepted 0 1563.38 2586 3472.125 3724.875 3884.5 3897 3897 II) 20% of the Sales 0.00 1250.70 2068.80 2777.70 2979.90 3107.60 3117.60 3117.60 311III) Margin Required [ I minus II ] 0.00 312.68 517.20 694.43 744.98 776.90 779.40 779.40 7IV) Margin (NWC) available 226.87 1504.31 1843.49 1820.66 2008.81 2214.8 2857.63 3725.45 400

    V) Item [ I ] minus Item [ III ] 0.00 1250.70 2068.80 2777.70 2979.90 3107.60 3117.60 3117.60 311VI) Item [ I ] minus Item [ IV ] -226.87 59.07 742.51 1651.465 1716.065 1669.7 1039.37 171.55 -10VI) higher of ( V ) or( VI ) 0 1250.7 2068.8 2777.7 2979.9 3107.6 3117.6 3117.6 3Recommended Bank Finance 0 1250.7 2068.8 2777.7 2979.9 3107.6 3117.6 3117.6 3

  • 8/10/2019 Final Cma Data

    21/25

    Past Financial Brief 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    TNW 704.72 1142.06 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62 5930.24TOL/TNW 7.77 6.27 6.59 5.10 3.59 2.55 1.90 1.49 1.08

    CURRENT RATIO 1.15 1.95 1.62 1.55 1.57 1.60 1.78 2.00 2.09NET SALES 0 6253.52 10344 13888.5 14899.5 15538 15588 15588 15588OPERATING PROFIT 31.6 147.85 330.21 430.44 749.25 804.02 911.07 1027.32 1101.54PBDIT 33.67 856.92 1787.54 1927.91 2119.94 2041.12 2014.72 1994.36 1972.98NET PROFIT (PAT) 30.57 203.34 292.83 381.72 666.71 713 807.94 898.73 944.26ROCE - % (PAT + INTT/TNW+SEC.TL+UNS.TL+BB)) 0.72% 13.34% 14.64% 16.87% 19.48% 19.34% 18.87% 17.55% 16.44%

    total Debt Equit Ratio 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Debt Inclduing BB 5477.62 7156.52 10130.37 9795.64 9206.42 8359.93 7774.24 7434.77 6375.63

    TNW 704.72 1142.06 1537.62 1919.34 2565.95 3278.95 4086.89 4985.62 5930.24Debt Equity Ratio 7.77 6.27 6.59 5.10 3.59 2.55 1.90 1.49 1.08

    Fixed Assets Coverage Ratio

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Net Fixed Assets 3899.46 5207.68 6808.69 6252.14 5749.60 5295.61 4885.26 4514.17 4178.38Secured Term Loan 0.00 0.00 2006.00 1872.00 1605.00 1204.00 803.00 401.00 0.00FACR #DIV/0! #DIV/0! 3.39 3.34 3.58 4.40 6.08 11.26 #DIV/0!

    Interest Coverage Ratio 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Profit After Tax 30.57 203.34 292.83 381.72 666.71 713 807.94 898.73 944.26Depreciation + Exp w/o 0 229.35 598.96 556.55 502.54 453.99 410.34 371.09 335.79Interest 0.00 424.23 858.37 940.92 868.15 783.11 693.31 595.95 535.65Total 30.57 856.92 1750.16 1879.19 2037.4 1950.1 1911.59 1865.77 1815.7Interest 0.00 424.23 858.37 940.92 868.15 783.11 693.31 595.95 535.65Interest Coverage Ratio #DIV/0! 2.02 2.04 2.00 2.35 2.49 2.76 3.13 3.39

    Debt Service Coverage Ratio

  • 8/10/2019 Final Cma Data

    22/25

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    Profit After Tax 30.57 203.34 292.83 381.72 666.71 713 807.94 898.73 944.26Depreciation 0 229.35 598.96 556.55 502.54 453.99 410.34 371.09 335.79Interest 0.00 424.23 858.37 940.92 868.15 783.11 693.31 595.95 535.65Total (A) 30.57 856.92 1750.16 1879.19 2037.4 1950.1 1911.59 1865.77 1815.7

    Repayment of Term loan 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00Interest 0.00 424.23 858.37 940.92 868.15 783.11 693.31 595.95 535.65Total (B) 0.00 424.23 858.37 940.92 868.15 783.11 693.31 595.95 535.65DSCR #DIV/0! 2.02 2.04 2.00 2.35 2.49 2.76 3.13 3.39

  • 8/10/2019 Final Cma Data

    23/25

    Break Even Analysis

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17 31.03.18 31.03.19audited audited estimated projected projected projected projected projected projected

    sales 0.00 6,253.52 10,344.00 13,888.50 14,899.50 15,538.00 15,588.00 15,588.00 15,58

    vairable Expenses -31.60 5,116.55 8,078.81 11,475.68 12,289.80 13,001.03 13,064.56 13,084.92 13,10

    Contribution 31.60 1,136.97 2,265.19 2,412.82 2,609.70 2,536.97 2,523.44 2,503.08 2,48

    Fixed Expenses 0.00 989.12 1,934.98 1,982.38 1,860.45 1,732.95 1,612.37 1,475.76 1,38

    PV Ratio #DIV/0! 1.15 1.17 1.22 1.40 1.46 1.57 1.70

    BEP Sales #DIV/0! 5,440.32 8,836.09 11,410.83 10,621.82 10,613.68 9,960.06 9,190.34 8,669

    % BEP Sales #DIV/0! 87.00 85.42 82.16 71.29 68.31 63.90 58.96

  • 8/10/2019 Final Cma Data

    24/25

    Financial High Lights

    31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17audited audited estimated projected projected projected projected

    Secured Term Loan 0 0 2006 1872 1605 1204 803Unsecured Loan 0.00 25.15 25.15 25.15 25.15 25.15 25.15Bank Borrowings 792.38 1115.53 2437.52 2730.94 2948.23 3051.46 3041.23Current Assets 1728.57 3090.9 4796.75 5133.19 5559.12 5879.62 6512.22Other Current Liabilities 709.32 471.06 515.74 581.59 602.08 613.36 613.36Current Ratio (incl : TL) 1.15 1.95 1.62 1.55 1.57 1.60 1.78Term debt equity ratio 5.64 4.88 4.67 3.38 2.20 1.43 1.01TOL/TNW 7.77 6.27 6.59 5.10 3.59 2.55 1.90

    Profitability Projections

    FY 31.03.11 31.03.12 31.03.13 31.03.14 31.03.15 31.03.16 31.03.17audited audited estimated projected projected projected projected

    Installed Capacity Tpa

    Capacity Utilisation%

    Net Sales 0.00 6253.52 10344.00 13888.50 14899.50 15538.00 15588.00Other Income 2.07 55.49 0 0 0 0 0Total Revenue 2.07 6309.01 10344.00 13888.50 14899.50 15538.00 15588.00Raw Material 0 3792.53 5084.69 6773.75 7290.36 7692.26 7692.26Consumable Stores 0.00 0.00 1,647.22 2,073.79 2,235.59 2,384.23 2,384.23Salary & wages 0.00 262.44 335.00 351.75 369.34 387.80 407.19Power 0.00 130.00 1,305.92 1,691.73 1,811.26 1 ,894.48 1,894.48Other Expenses 0.00 1,116.91 490.88 617.76 661.44 686.40 686.40Cost of Production -4.63 5,517.88 9,005.08 12,049.72 12,833.45 13,478.34 13,474.90Cost of Sales -31.60 5,345.90 8,677.77 12,032.23 12,792.34 13,455.02 13,474.90Amortization 0 0 0 0 0 0 0PBDIT

    33.67 856.92 1787.54 1927.91 2119.94 2041.12 2014.72Depreciation 0.00 229.35 598.96 556.55 502.54 453.99 410.34Interest 0.00 424.23 858.37 940.92 868.15 783.11 693.31Profit Before ax 33.67 203.34 330.21 430.44 749.25 804.02 911.07Provision for Tax 3.1 0 37.38 48.72 82.54 91.02 103.13Proftit after Tax 30.57 203.34 292.83 381.72 666.71 713.00 807.94PBDIT Margin% #DIV/0! 13.70% 17.28% 13.88% 14.23% 13.14% 12.92%PAT/Sales% #DIV/0! 3.25% 2.83% 2.75% 4.47% 4.59% 5.18%

    Particulars

    Equity/Preference share Capital 234.47 304.97 345.8

    3304.10

    345.8

    TNW Including unsecured loan 2591.101167.21 1562.77 1944.49704.72

    345.8345.8 345.8

    4112.04

  • 8/10/2019 Final Cma Data

    25/25

    31.03.18 31.03.19projected projected

    401 0

    25.15 25.153103.76 3045.627442.57 7663.84613.36 613.36

    2.00 2.090.75 0.461.49 1.08

    31.03.18 31.03.19projected projected

    15588.00 15588.000 0

    15588.00 15588.007692.26 7692.262,384.23 2,384.23427.55 448.93

    1,894.48 1,894.48686.40 686.40

    13,456.01 13,442.0913,456.01 13,442.09

    0 01994.36 1972.98371.09 335.79595.95 535.65

    1027.32 1101.54128.59 157.28898.73 944.2612.79% 12.66%5.77% 6.06%

    345.8

    5955.395010.77

    345.8